| | |
| Clinical data | |
|---|---|
| Other names | 3,4-Methylenedioxy-N-hydroxyethylamphetamine; MDOHET; MDHET; MDHEA; N-Hydroxyethyl-MDA |
| Routes of administration | Oral [1] |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | Unknown [1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C12H17NO3 |
| Molar mass | 223.272 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
MDHOET, also known as 3,4-methylenedioxy-N-hydroxyethylamphetamine or as N-hydroxyethyl-MDA, is a lesser-known drug and a substituted amphetamine. [1] It is also the N-hydroxy ethyl analogue of MDA. [1]
In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists MDHOET's dose as greater than 50 mg orally and its duration as unknown. [1] MDHOET produced few to no effects. [1]
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act. [2]